The company states that the oil delivers 60% DHA.
Aker BioMarine (Oslo, Norway) has announced the launch of a new algae oil, called FloraMarine, at this year’s Natural Products Expo West. The company states that the oil delivers 60% DHA in one dose for the highest, natural concentration of algae DHA on the market. According to the company, FloraMarine does not have to be up-concentrated unlike standard natural triglyceride and algae oils which become altered molecularly into ethyl esters and re-esterified triglyceride molecules.
“Red meets green is one of the best ways to describe the addition of FloraMarine to our ingredient portfolio,” said Simon Seward, chief executive officer of Human Health Ingredients for Aker BioMarine, in a press release. “While krill oil remains the flagship ingredient in our business, we recognize the need for a high-quality plant-based omega-3 source that delivers valuable DHA with specific effects on a wide range of functions including brain, eye, maternal and fetal health. At a time when the marine omega-3 category is facing supply challenges due to climate and environmental impacts, which limit the availability of traditional fish oil, we are offering a unique and stable solution to the industry.”
The product is also made in-house by Aker BioMarine, utilizing existing crude oil plant in Houston, TX. “So, we have a really favorable cost-positioning and can be really competitive because basically all our costs are already covered from the krill side,” said Matts Johansen, CEO of AkerBiomarine to Nutritional Outlook. “And then of course, using the experience we have of building krill from nothing into quite a large segment today. We see that we can play a role in building algae in a similar way because it’s a great product that deserves its place out in the market.”
“Like we have shown in the krill oil industry, we have strong ambitions and an excellent track record of bringing unique, innovative, and novel sources of omega-3 to the industry. Our capabilities to extract various ingredients at our Houston manufacturing facility will help give us that competitive advantage,” said Seward, in a press release.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.